Oxford Genetics, a provider of synthetic biology-based technologies for biologics discovery, development and delivery, has opened its first U.S. office located at the NGIN workplace near Kendall Square in the Cambridge district of Boston, MA. By expanding into the U.S. market, the company says it is well positioned to respond to its existing customers’ needs, while also leveraging the very attractive sector and growing market. This is the company’s first office outside of the UK, and will ...